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Abstract
Background
We aimed to determine how linear growth and fat and lean tissue gain during discrete age
periods from birth to adolescence are related to adolescent cardiometabolic risk factors and
cognitive ability.
Methods
Adolescents born to mothers with normal glucose tolerance during pregnancy from an
Indian birth cohort (N = 486, age 13.5 years) had detailed anthropometry and measure-
ments of body fat (fat%), fasting plasma glucose, insulin and lipid concentrations, blood
pressure and cognitive function. Insulin resistance (HOMA-IR) was calculated. These out-
comes were examined in relation to birth measurements and statistically independent mea-
sures (conditional SD scores) representing linear growth, and fat and lean tissue gain
during birth-1, 1–2, 2–5, 5–9.5 and 9.5–13.5 years in 414 of the children with measurements
at all these ages.
Results
Birth length and linear growth at all ages were positively associated with current height. Fat
gain, particularly during 5–9.5 years was positively associated with fat% at 13.5 years (0.44
SD per SD [99.9% confidence interval: 0.29,0.58]). Greater fat gain during mid-late child-
hood was associated with higher systolic blood pressure (5–9.5 years: 0.23 SD per SD
[0.07,0.40]) and HOMA-IR (5–9.5 years: 0.24 [0.08,0.40], 9.5–13.5 years: 0.22 [0.06,0.38]).
Greater infant growth (up to age 2 years) in linear, fat or lean components was unrelated to
cardiometabolic risk factors or cognitive function.
PLOS ONE | DOI:10.1371/journal.pone.0143231 November 17, 2015 1 / 14
OPEN ACCESS
Citation: Krishnaveni GV, Veena SR, Srinivasan K,
Osmond C, Fall CHD (2015) Linear Growth and Fat
and Lean Tissue Gain during Childhood: Associations
with Cardiometabolic and Cognitive Outcomes in
Adolescent Indian Children. PLoS ONE 10(11):
e0143231. doi:10.1371/journal.pone.0143231
Editor: Monika R. Asnani, Sickle Cell Unit, JAMAICA
Received: August 6, 2015
Accepted: November 2, 2015
Published: November 17, 2015
Copyright: © 2015 Krishnaveni et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: The study data are not
freely available due to legal restrictions, and
Government of India’s Health Ministry Screening
Committee (HMSC) assessment is required to obtain
the data. The Parthenon Cohort team will provide the
data on request subject to HMSC approval. For
further information contact the corresponding author:
Dr. GV Krishnaveni (gv.krishnaveni@gmail.com). 1)
Details of legal and ethical restrictions behind these
data: Legal restrictions: Appraisal is required from the
Health Ministry Screening Committee (HMSC),
Government of India, to share the data with foreign
researchers or with researches funded by foreign
Conclusion
This study suggests that factors that increase linear, fat and lean growth in infancy have no
adverse cardiometabolic effects in this population. Factors that increase fat gain in mid-late
childhood may increase cardiometabolic risk, without any benefit to cognitive abilities.
Introduction
Recent research has shown that birth weight, and childhood weight gain, are related to adult
cardiovascular and metabolic health. Associations of weight at different ages between birth and
adulthood with cardiometabolic outcomes have shown opposing directions; for example lower
birth weight, but greater childhood weight gain, are consistently associated with a higher risk
of adult cardiovascular disease (CVD) and type 2 diabetes (T2DM) [1–3]. Weight gain during
infancy (the first 1–2 postnatal years) is less consistently related to these outcomes; while some
studies have shown that higher infant weight gain is associated with a lower adult CVD and
T2DM risk [1–3], others have shown an increased obesity and cardiometabolic risk [4–5], and
others have found no associations [6]. This creates a dilemma for paediatricians in low- and
middle-income countries (LMIC) who, given high rates of low birth weight and infant growth
faltering, tend to promote early weight gain. This strategy is thought to improve survival and
protect neurodevelopment, but may exacerbate later non-communicable disease (NCD) risk
[7].
Adair et al. recently showed the importance of distinguishing linear growth from ‘soft tissue’
growth [8]. They used a new 2-way method of conditional growth analysis to examine associa-
tions of height growth independent of weight gain, and weight gain independent of height
growth (relative weight gain), during discrete age periods, with adult cardiometabolic and
human capital outcomes using longitudinal data from five LMIC cohorts (Consortium on
Health Oriented Research in Transitional Societies/COHORTS). Greater relative weight gain
at all postnatal ages was associated with higher body mass index (BMI), fat mass, fat-free mass,
blood pressure (BP) and diabetes risk, but these associations were markedly strong for weight
gain after mid-childhood (4–8 years of age). In contrast, linear growth from birth-2 years was
positively associated with human capital outcomes such as adult stature and attained schooling,
only weakly positively associated with BP, and unrelated to diabetes risk. They concluded that
promoting weight gain from mid-childhood onwards may substantially increase adiposity and
NCD risk, while promoting linear growth during infancy is likely to benefit human capital
without NCD risk. A limitation of their analysis was the inability to separate weight gain into
fat and fat-free gain, because the only measurements available were height and weight.
We have now extended their method to a 3-way conditional analysis, using data from an
Indian birth cohort, in which children had detailed anthropometry from birth to 13.5 years of
age [9]. This enabled an analysis of the independent associations of linear (height) growth, fat
(skinfolds) gain, and non-fat weight gain (residual weight) during discrete postnatal age peri-
ods with cardiometabolic and cognitive outcomes at 13.5 years. We hypothesised that greater
linear growth and non-fat weight gain, especially in infancy, would be associated with lower
cardiometabolic risk factors and higher cognitive function score, while greater fat gain at all
ages, especially in mid-late childhood, would be associated with greater general and central adi-
posity and higher cardiometabolic risk factors.
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Methods
Mysore Parthenon Cohort
During 1997–1998, 830 women attending the antenatal clinics of the Holdsworth Memorial
Hospital (HMH), Mysore, India, and matching our eligibility criteria (no known history of dia-
betes, intention to deliver at HMH, singleton pregnancy) had an oral glucose tolerance test
(OGTT) at 30±2 weeks gestation; 785 women completed the OGTT (S1 Fig). Gestational dia-
betes mellitus (GDM) was diagnosed in 49 women using the Carpenter-Coustan criteria [10].
Six-hundred and sixty-three of these women delivered live babies without major congenital
anomalies at HMH. Neonatal anthropometry, including weight, crown-heel length, and sub-
scapular and triceps skinfold thickness, was performed within 72-hours of birth as described
before [11]. On follow-up, 25 children died, and 8 were excluded because of major medical
conditions. Anthropometry, including measurements of height, weight and subscapular and
triceps skinfold thickness was performed in the remaining children annually until 5 years of
age, and 6-monthly thereafter. Fat and fat-free mass were measured using bioimpedance from
5-year onwards.
Anthropometric measurements were standardized by regular inter- and intra-observer vari-
ation studies. The inter-observer co-efficient of variation (CV) was<1% for weight and crown-
heel length/ height at birth and subsequent follow-up points. The inter-observer CV for triceps
skinfold thickness was 2.1% at birth, 0.4% during infancy and6% during 5 and 9.5 year fol-
low-ups. For subscapular skinfold thickness, CV ranged from 3.7% at birth and infancy to 8.2%
at 5 year follow-up.
At 13.5 years, 545 children were available for follow-up. Detailed anthropometry was per-
formed, including the measurements of weight (Salter, Tonbridge, Kent, UK), height (Micro-
toise, CMS instruments, UK), and triceps and subscapular skinfold thickness measurements
(Harpenden callipers, CMS instruments). The inter-observer CV was<1% for height and
weight, 1.3% for triceps and 4.5% for subscapular skinfold thickness. Percentage body fat (fat
%) was measured using bioimpedance (Bodystat, Quadscan 4000, Isle of Man, UK). This
method has been shown to give reliable estimates of fat and fat-free mass [12,13]. We have pre-
viously observed in a subgroup of the present cohort that bioimpedance method was useful for
measuring group-level changes in body fat [14].
Systolic and diastolic blood pressure (BP) were measured using an automated BP monitor
(Dinamap 8100, Criticon, FL, USA). Waist-to-hip ratio (WHR) was calculated from waist and
hip circumferences as a measure of central adiposity. Pubertal growth was assessed as the stage
of breast development in girls and genital development in boys using Tanner’s method [15].
The socio-economic status (SES) of the family was determined using the Standard of Living
Index designed by the National Family Health Survey-2 [16]. Plasma glucose, insulin and lipid
concentrations were measured using fasting blood samples. Assays were carried out at the Dia-
betes Unit, KEM Hospital, Pune, India, whose laboratory is a member of the UK National
External Quality Assessment Service (NEQAS) quality control programme for insulin assays.
Glucose and lipid concentrations were measured by standard enzymatic methods (Hitachi-
902, Roche, Germany). Insulin was measured using the enzyme-linked immunosorbent assay
(Mercodia Ultrasensitive, Mercodia AB, Uppsala, Sweden). Inter- and intra-assay CV was
<7.0%. Insulin resistance was estimated using Homeostasis Model Assessment for insulin
resistance (HOMA-IR) [17].
Cognitive function was assessed using tests from the Kaufman Assessment Battery for chil-
dren-second edition, 2004 and additional tests as described before [18]. These tests had been
adapted and validated to ensure their applicability in the local cultural context [19]. The cogni-
tive domains tested were short-term memory (Word order, Coding), long-term memory and
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retrieval ability (Atlantis), visuo-spatial ability (Koh’s block design), reasoning (Pattern reason-
ing) and language production (Verbal fluency). All tests were administered to each child in a
single session of 60–90 min at the hospital research centre, in a separate quiet room by one of 3
trained masters’ level child psychologists in the local Kannada language. The inter-observer
CV was<1% for all the tests except verbal fluency (1.8%). In addition to the individual test
scores, a mean cognitive score as the average of all the individual scores was calculated.
The Holdsworth Memorial Hospital ethics review committee approved the study, and
informed written consent was obtained from the parents and assent from children.
Statistical methods
Assessment of size and growth. Within an individual, different body measurements at a
given age, and the same body measurement at different ages, are strongly correlated. This
makes it difficult to assess the relationship of the growth of specific tissues during specific age
periods to later outcomes. Conditional growth analysis, in which standardised residuals are
derived from regressing current size on all prior size measurements, is one way of overcoming
this (Fig 1a) [20]. It has been most commonly applied to single body measurements such as
weight or height (Fig 1a) [21]. Adair and colleagues developed the method further by combin-
ing two measurements (weight and height; Fig 1b) [8]. Conditional height (representing linear
growth independent of weight gain) was current height accounting for all prior height and
weight measures but not current weight, and weight gain independent of linear growth was
current weight accounting for current height and all prior weight and height measures. In the
current analysis we combine three measurements (height, sum of skinfold thickness and
weight) (Fig 1c). We used skinfold thickness measurements rather than fat mass measured
using bioimpedance method as this was not measured serially from birth. Conditional length/
height (representing ‘linear growth’) is current length/height accounting for all prior length/
height, skinfold and weight measurements but not current skinfolds and weight; conditional
fat (representing ‘fat gain’) is current skinfold thickness accounting for all prior length/height,
skinfolds and weight, and current height but not current weight; and conditional lean (repre-
senting ‘lean tissue gain’) is current weight accounting for all prior length/height, skinfolds and
weight and current height and skinfolds.
The conditional variables measure the difference between the size attained and that
expected from the child’s earlier size measurements and selected current measurements, using
data from the whole cohort. A positive value indicates greater (or faster) than expected growth,
and a negative value indicates less (or slower) growth than expected. An advantage of this
method is that, by construction, the conditional variables at all ages for any individual are
uncorrelated with each other, and can be included together in a regression model. A disadvan-
tage is that conditional variables can only be used for those who have valid measurements at
every age chosen. In the current study, birth, 1, 2, 5, 9.5 and 13.5 years were selected, to repre-
sent growth in early-infancy (birth-1 year), late-infancy (1–2 years), early-childhood (2–5
years), mid-childhood (5–9.5 years) and late-childhood (9.5–13.5 years). We excluded off-
spring born to diabetic mothers and those whose mothers’ GDM status was unknown. Before
deriving the conditional variables, size measurements at the selected ages were converted into
SD scores, separately for boys and girls, adjusting for exact age at measurement, using Fisher-
Yates’ transformation. The conditional variables themselves (residuals) are also expressed as
SD scores. Conditional height, fat and lean variables were derived for all available children, sep-
arately for boys and girls, at each age interval.
Examining the association between conditional growth and outcomes at 13.5 years. At
13.5 years, 486 children born to normal glucose tolerant mothers were available for follow-up.
Postnatal Growth and Adolescent Risk Markers
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Fig 1. Schematic Diagram to Show the Commonly Used and Extended Methods of Deriving Conditional Growth Variables.H: height/length; S: sum
of skinfold thickness; W: weight. Each pyramid shows the calculation of a set of conditional variables; (a) shows the use of a single measurement eg. weight
or height; (b) shows two measurements combined (weight and height); and (c) shows three measurements as used in our analysis (height, skinfolds and
weight). Within each pyramid, each row shows the calculation of one conditional variable, from length at birth at the top to (at the base) 13.5 year conditional
weight or height (a), conditional relative weight (b) or conditional lean tissue gain (c). These variables are measures of the residuals from regression models
in which the measure to the left of the vertical bar is the outcome, and measures to the right of the vertical bar are the predictors. (a): In the first method,
current weight or height was conditioned respectively on all previous measurements of the same type. (b): In the second method described by Adair et al (8),
‘linear growth’ was current height conditioned on all previous height and weight measurements; ‘relative weight gain’ was current weight conditioned on
current height and all previous weight and height measures. (c): In our extended method, ‘linear growth’ was current height conditioned on all previous height,
skinfold and weight measurements; ‘fat gain’was current skinfold thickness conditioned on current height and all previous height, skinfold and weight
measures; ‘lean tissue gain’ was current weight conditioned on current height and skinfolds, and all previous height, skinfold and weight measures.
doi:10.1371/journal.pone.0143231.g001
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The analysis was restricted to 414 children who had all the required growth measurements at
all ages (85% of eligible children followed up at 13.5 years). Outcome variables (anthropometry,
body composition, cardiometabolic risk factors and cognitive function) at 13.5 years were con-
verted into SD scores using Fisher-Yates’ transformation, to enable comparison of effects
across outcomes. Linear regression analysis was used to examine associations of conditional
height, fat and lean with outcomes, adjusted for age, sex, SES and pubertal stage. Due to a high
degree of correlation between growth variables and current anthropometry, we did not addi-
tionally adjust for current size or fat measurement in these models. Growth variables for the
9.5–13.5 year interval were not included in the models for anthropometry and body composi-
tion outcomes as, by construction, these variables also included relevant 13.5 year measure-
ments. Effect sizes with 99.9% confidence intervals (CI), equivalent to a P-value of<0.001, are
presented, rather than 95% CI (P<0.05), to account for multiple testing. Data were analysed
using SPSS v 21 (IBM Corp, NY, USA).
Results
Table 1 describes the general characteristics of the children included for the current analysis.
Included children tended to have higher skinfold thickness measurements at 2- and 5-year fol-
low-up rounds compared to those not studied (S1 Table). There was no difference between the
studied and not studied children in other growth variables at different age points, or outcomes
at 13.5 years.
Girls who had faster linear growth (0.33 SD per SD [99.9% CI: 0.13,0.53]) and greater lean
tissue gain from 5–9.5 years (0.20 SD per SD [0.01,0.40]) were at a more advanced breast devel-
opment stage; there was no association between conditional growth and pubertal development
in boys.
Conditional growth and height and body composition at 13.5 years
Length at birth and linear growth at all age intervals from birth-9.5 years were strongly posi-
tively associated with current height (Fig 2, S2 Table). Faster linear growth, especially from
5–9.5 years was associated with higher BMI and sum of skinfold thickness; but there were no
associations with WHR and fat% from bioimpedance. More fat at birth was associated with
shorter current height. Fat at birth, and fat gain during infancy and childhood were positively
associated with current BMI and skinfold thickness. Only fat gain during childhood was posi-
tively associated with WHR and fat%. Greater lean tissue gain at all ages after birth was associ-
ated with higher 13.5-year BMI. Greater lean tissue gain from 2–5 years was also associated
with larger skinfold thickness.
Conditional growth and cardiometabolic and cognitive outcomes at 13.5
years
There were no associations of length or lean tissue at birth, or of linear or lean tissue growth at
any age with current cardiometabolic risk outcomes (Fig 3, S3 Table). Fat gain after 5 years was
positively associated with systolic BP, fasting insulin concentrations and HOMA-IR.
There were no associations between linear growth, fat gain or lean tissue gain at any age
interval and current cognitive function (S4 Table).
There were no interactions between sex and growth parameters in relation to the outcomes
reported above.
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Table 1. Characteristics of the Children at Birth, and at 1, 2, 5, 9.5 and 13.5 Years of Age.
N Boys (N = 208) Girls (N = 206)
Birth
Gestation (weeks) 414 39.0 (1.7) 39.2 (1.6)
Crown-heel length (cm) 414 48.9 (2.3) 48.3 (2.1)
Sum of skinfold thickness (mm) 414 8.3 (1.6) 8.1 (1.6)
Weight (kg) 414 2.906 (0.465) 2.803 (0.388)
One year
Age (yr) 414 1.00 (0.03) 1.00 (0.03)
Crown-heel length (cm) 414 74.0 (2.7) 72.2 (2.7)
Sum of skinfold thickness (mm) 414 14.5 (2.7) 14.4 (2.9)
Weight (kg) 414 8.8 (1.0) 8.0 (1.0)
Two years
Age (yr) 414 2.00 (0.03) 2.00 (0.02)
Crown-heel length (cm) 414 84.4 (3.2) 82.6 (3.1)
Sum of skinfold thickness (mm) 414 14.5 (2.7) 14.4 (2.9)
Weight (kg) 414 10.8 (1.2) 10.2(1.3)
Five years
Age (yr) 414 5.00 (0.04) 5.00 (0.03)
Height (cm) 414 106.3 (4.3) 104.9 (4.3)
Sum of skinfold thickness (mm) 414 12.9 (2.6) 15.1 (3.6)
Weight (kg) 414 15.4 (2.0) 14.9 (2.0)
9.5 years
Age (yr) 414 9.35 (0.10) 9.36 (0.11)
Height (cm) 414 131.3 (5.5) 130.1 (5.9)
Sum of skinfold thickness (mm) 414 15.8 (5.6) 19.6 (6.0)
Weight (kg) 414 25.2 (4.3) 24.7 (4.4)
13.5 years
Age (yr) 414 13.53 (0.14) 13.53 (0.14)
SES (score) 414 39.1 (6.8) 38.2 (7.2)
Pubertal stage (N): 2/3/4a 404 8/44/148 (4/22/74) 40/109/55 (20/53/27)
Height (cm) 414 154.5 (7.7) 152.9 (5.7)
Sum of skinfold thickness (mm) 414 23.0 (12.7) 30.0 (10.3)
Weight (kg) 414 40.7 (8.7) 42.7 (8.0)
Body Fat (%) 414 17.2 (6.6) 25.6 (5.8)
Systolic BP (mmHg) 414 111.2 (8.3) 107.3 (7.8)
Diastolic BP (mmHg) 414 63.0 (6.8) 59.3 (6.9)
Glucose 0 (mmol/l) 409 5.0 (0.5) 5.0 (0.5)
Insulin 0 (pmol/l) b 409 33.4 (21.6,46.7) 44.5 (34.8,58.3)
HOMA-IR b 409 1.2 (0.8,1.8) 1.7 (1.3,2.1)
Total cholesterol (mmol/l) 409 3.5 (0.7) 3.5 (0.7)
Triglycerides (mmol/l) 409 0.8 (0.5) 0.9 (0.4)
HDL-Cholesterol (mmol/l) 409 1.09 (0.27) 1.04 (0.23)
Koh’s Block Design (score) c 414 84.4 (26.7) 82.7 (26.0)
Verbal Fluency (score) c 414 19.8 (4.8) 22.9 (6.1)
Atlantis (score) c 414 79.8 (14.6) 80.7 (13.9)
Pattern Reasoning (score) c 414 14.8 (6.6) 16.3 (6.7)
Word Order (score) c 414 18.5 (3.5) 19.2 (3.9)
Coding (score) c 414 44.2 (10.0) 50.4 (11.3)
(Continued)
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Discussion
This study exploring associations of linear growth, fat gain and lean tissue gain during different
age intervals in infancy and childhood with health-related outcomes at 13.5 years of age
showed that faster fat gain in mid-late childhood predicts greater fat% and central adiposity,
and higher systolic BP and insulin resistance (HOMA-IR). Although greater neonatal fat and
greater fat gain during infancy were associated with greater BMI and skinfolds, they were not
associated with cardiometabolic risk factors. Contrary to our hypothesis, there was no evidence
for associations of faster linear growth and greater lean tissue gain during early life with a more
favourable cardiometabolic or cognitive outcomes.
Major strengths of the study were the availability of detailed neonatal and postnatal anthro-
pometry, including skinfold thickness measurements, and the assessment of risk factors in a
large group of healthy adolescents. Though previous studies have examined the independent
effects of linear growth and relative weight gain on later cardiovascular and human capital
measures, this is the first study to use a 3-way conditional analysis to separate the effects of
lean and fat gain from relative weight gain in childhood. We examined associations of growth
in children without intra-uterine exposure to hyperglycemia, which is known to influence body
size and risk outcomes [22]. A limitation was that about 15% of the children who were fol-
lowed-up at 13.5 years were not included because they did not have growth measurements
available at all age intervals. This could have introduced selection bias, though birth and post-
natal anthropometry, and outcome measurements were generally similar in the included and
excluded children. Our longitudinal measures of body composition based on anthropometry
could be considered rather a crude method of assessing fat and lean mass. Methods such as
bioimpedence, dual X-ray absorptiometry (DXA) or doubly-labelled water studies may be
more precise. Though bioimpedance was used to measure body fat in later follow-up years in
our study, unavailability of these measurements at birth and during infancy precluded their use
in the construction of growth variables. However, to our knowledge, no cohorts have used
these sophisticated methods at frequent intervals throughout infancy and childhood. Bioimpe-
dence and DXA are difficult to perform in infants, serial DXA measurements would be pre-
cluded in children due to radiation exposure, and doubly-labelled water would be time-
consuming [23].
Growth during different stages of the lifecourse has been thought to influence later health
outcomes differently, though observations have not been consistent. In New Delhi, India,
young adults who developed T2DM and glucose intolerance had a lower BMI during infancy,
but had accelerated childhood weight or BMI gain [3]. In Pune, greater gain in all measure-
ments after six months of age was associated with higher CVD risk markers at six years [24]. In
Table 1. (Continued)
N Boys (N = 208) Girls (N = 206)
Mean cognitive score (score) 414 43.6 (7.7) 45.4 (7.6)
SES: Socio-economic status; BP: Blood pressure; HOMA-IR: Homeostasis Model Assessment insulin resistance. Values given are mean (SD), Pubertal
stage represents breast development stage in girls and genital development stage in boys; Sum of skinfold thickness is the sum of triceps and
subscapular skinfold thickness.
a N (%) or
b median (IQR).
c The cognitive domains tested were visuo-spatial ability (Koh’s block design), language production (Verbal ﬂuency), long-term memory and retrieval ability
(Atlantis), reasoning (Pattern reasoning) and short-term memory (Word order, Coding)
doi:10.1371/journal.pone.0143231.t001
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Fig 2. Associations of Linear Growth and Fat and Lean Tissue Gain with Height, Fat% andWaist-to-Hip Ratio at 13.5 Years. Values represent
standard deviation/SD (99.9% confidence interval) change in outcome per SD change in growth variable.
doi:10.1371/journal.pone.0143231.g002
Postnatal Growth and Adolescent Risk Markers
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Fig 3. Associations of Conditional Linear Growth and Fat and Lean Tissue Gain with Systolic Blood Pressure (BP) and HOMA-IR. Values represent
standard deviation/SD (99.9% confidence interval) change in outcome per SD change in growth variable.
doi:10.1371/journal.pone.0143231.g003
Postnatal Growth and Adolescent Risk Markers
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the Avon Longitudinal Study of Parents and Children in the UK, weight and height gain both
during infancy and childhood predicted higher systolic BP at 10 years; the association was
strongest for post-infancy weight gain [25]. In the COHORTS data, weight gain and/or linear
growth during infancy was associated with increased fat-free mass [26], taller adult height [27]
and more attained schooling [28]. Most of these studies assessed growth using either weight or
height gain. Therefore, due to strong correlations between different body measurements, inde-
pendent effects of components of size are not clear. Adair et al. attempted to overcome this
issue by disentangling the effects of linear growth and relative weight gain, and showed that
rapid linear growth during the first two years of life was associated with increased adult height
and schooling [8]. Higher relative weight gain in mid-late childhood was associated with an
increased risk of adult overweight, elevated BP and diabetes.
Our extended conditional method further elucidates the independent influences of linear
growth, fat gain and lean tissue gain during infancy and childhood on later outcomes. Children
who had a greater gain in the fat component of relative weight gain, particularly during mid-
late childhood, developed higher cardiometabolic risk markers. There were no obvious adverse
or beneficial associations of faster infant linear, fat or lean tissue growth with cardiometabolic
and cognitive outcomes. It is encouraging that later linear and lean tissue growth did not seem
to predict higher cardiometabolic risk. This may have important implications for improving
quality of life through promoting growth in these components in those who had compromised
early growth, because linear and lean tissue gain even in childhood is important for optimum
adulthood body composition [29]. Greater length at birth and faster linear growth at all ages
were related to increased current height as expected. Interestingly, greater neonatal fat was
related to shorter current height. This may reflect the fat-sparing effect described in growth-
retarded Indian babies (thin-fat phenotype) [30], who are more likely to be stunted in later
childhood [31]. As paternal height is an important predictor of the skeletal and fat-free tissue
growth in the fetus [32], offspring born to short fathers, who are likely to attain shorter final
height themselves, may have increased relative adiposity at birth.
Notably, linear and lean growth during infancy was not related to cognitive performance in
our study. Considering the importance of early growth for optimum neuro-cognitive develop-
ment, we expected a strong association of infant growth on cognitive function. However, our
finding is consistent with a recent systematic review which showed a weak positive or no asso-
ciation of weight or height gain during infancy on subsequent cognitive function indices in
non-small-for-gestational-age children [33]. It has been suggested that adverse effects of early
nutritional deficiencies on cognitive function can be ‘corrected’ through appropriate environ-
mental and social stimuli even at a later developmental stage [34]. This may be a reason for an
absent relationship in our relatively homogenous sample of urban children, for whom the
opportunities for learning and environmental interactions are largely similar.
Conclusions
Previous studies have consistently shown that accelerated weight gain during late childhood
predicts greater adult NCD risk; our study suggests that this may correspond to increased fat
gain. The long-term implication of growth during infancy and early childhood needs further
study. While our findings suggest that early growth up to the age 5 years may have no subse-
quent adverse cardiometabolic implications, some studies, mainly from high-income settings,
have observed greater NCD risk in association with rapid infant weight gain. Similar analyses
to ours, or using more advanced serial body composition measurements through infancy and
childhood, in other populations, would help to clarify this issue. This is important for public
health strategies in countries like India where high rates of fetal growth retardation may lead to
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an increased prevalence of childhood morbidity and mortality. In these settings, infancy pro-
vides an important and effective window of opportunity to maximise survival by promoting
faster growth. Well-designed intervention studies may provide more conclusive evidence
regarding the benefits and risks of promoting early growth.
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